Rob M. Schipper

519 total citations
9 papers, 418 citations indexed

About

Rob M. Schipper is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Rob M. Schipper has authored 9 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Rob M. Schipper's work include Lung Cancer Treatments and Mutations (5 papers), Global Cancer Incidence and Screening (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Rob M. Schipper is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Global Cancer Incidence and Screening (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Rob M. Schipper collaborates with scholars based in Netherlands. Rob M. Schipper's co-authors include J.W.W. Coebergh, M.A. Crommelin, P. P. A. Razenberg, M.L.G. Janssen‐Heijnen, Jolanda C. M. van Haastregt, Harry Crebolder, Luc de Witte, Frank W.J.M. Smeenk, P J Klinkhamer and Paul J. J. M. Klinkhamer and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and Epidemiology.

In The Last Decade

Rob M. Schipper

8 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob M. Schipper Netherlands 7 269 195 74 49 35 9 418
Carol McPherson United States 9 191 0.7× 222 1.1× 46 0.6× 25 0.5× 26 0.7× 14 494
P. Hopwood United Kingdom 8 174 0.6× 186 1.0× 48 0.6× 43 0.9× 16 0.5× 29 390
Santino Butler United States 14 384 1.4× 246 1.3× 57 0.8× 40 0.8× 31 0.9× 33 626
Helen Powell United Kingdom 12 383 1.4× 222 1.1× 61 0.8× 49 1.0× 63 1.8× 18 656
Beverly Gor United States 11 129 0.5× 238 1.2× 61 0.8× 120 2.4× 12 0.3× 23 482
Gloria A DiLullo United States 5 180 0.7× 453 2.3× 32 0.4× 28 0.6× 26 0.7× 9 515
Terje Tollåli Norway 12 344 1.3× 297 1.5× 89 1.2× 58 1.2× 12 0.3× 21 536
Isra Levy Canada 13 137 0.5× 171 0.9× 102 1.4× 72 1.5× 18 0.5× 20 558
Pierre K. Isogai Canada 10 117 0.4× 198 1.0× 36 0.5× 25 0.5× 14 0.4× 24 448
Saku Torvinen Finland 13 334 1.2× 116 0.6× 41 0.6× 91 1.9× 10 0.3× 43 589

Countries citing papers authored by Rob M. Schipper

Since Specialization
Citations

This map shows the geographic impact of Rob M. Schipper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob M. Schipper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob M. Schipper more than expected).

Fields of papers citing papers by Rob M. Schipper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob M. Schipper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob M. Schipper. The network helps show where Rob M. Schipper may publish in the future.

Co-authorship network of co-authors of Rob M. Schipper

This figure shows the co-authorship network connecting the top 25 collaborators of Rob M. Schipper. A scholar is included among the top collaborators of Rob M. Schipper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob M. Schipper. Rob M. Schipper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Janssen‐Heijnen, M.L.G., et al.. (2001). Is There a Common Etiology for the Rising Incidence of and Decreasing Survival with Adenocarcinoma of the Lung?. Epidemiology. 12(2). 256–258. 36 indexed citations
2.
Janssen‐Heijnen, M.L.G., et al.. (2001). [Lung cancer in the Netherlands in the period 1989-1997: the epidemic is not over yet].. PubMed. 145(9). 419–23. 4 indexed citations
3.
Janssen‐Heijnen, M.L.G., Ronald Damhuis, P J Klinkhamer, Rob M. Schipper, & J.W.W. Coebergh. (1999). Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of The Netherlands since 1970. European Journal of Cancer Prevention. 8(4). 311–314. 23 indexed citations
4.
Schipper, Rob M., et al.. (1998). Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: A population-based study. Lung Cancer. 21(2). 105–113. 241 indexed citations
5.
Smeenk, Frank W.J.M., et al.. (1998). Transmural Care of Terminal Cancer Patients: Effects on the Quality of Life of Direct Caregivers. Nursing Research. 47(3). 129–136. 47 indexed citations
6.
Janssen‐Heijnen, M.L.G., Rob M. Schipper, P J Klinkhamer, et al.. (1998). Divergent changes in survival for histological types of non-small-cell lung cancer in the southeastern area of The Netherlands since 1975. British Journal of Cancer. 77(11). 2053–2057. 14 indexed citations
7.
Smeenk, Frank W.J.M., et al.. (1998). Transmural care. Patient Education and Counseling. 35(3). 189–199. 28 indexed citations
8.
Janssen‐Heijnen, Maryska L.G., Rob M. Schipper, P J Klinkhamer, M.A. Crommelin, & J.W.W. Coebergh. (1998). Improvement and plateau in survival of small-cell lung cancer since 1975: A population-based study. Annals of Oncology. 9(5). 543–547. 25 indexed citations
9.
Jaarsveld, Brigit C. van, et al.. (1988). [Chylothorax and chylopericardium].. PubMed. 132(34). 1584–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026